Breaks Categories: News

WednesdayAug 08, 2018 10:55 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Unveils Medicinal Cannabis Division’s First Product Development Program

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the first product development program of the company’s newly created medicinal cannabis division, which will focus on the development of cannabinoids as a preventative treatment for anxiety disorders using PreveCeutical’s proprietary Sol-gel delivery platform. Per the update, the goal of the medical cannabis division’s program is to “create an effective therapy for anxiety that can be administered subtly and infrequently, addressing concerns of currently available treatments for anxiety disorders.” According to data from the Mayo Clinic, common approaches to treating anxiety, such as the prescription…

Continue Reading

WednesdayAug 08, 2018 9:51 am

CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances $1M Capital Tranche to ezGreen Compliance

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that it has advanced $1 million to its investee company, ezGreen Compliance, which offers a state-of-the-art enterprise compliance and point-of-sale software solution for licensed medical cannabis dispensaries and cultivators. Per the update, FinCanna has now advanced $1.75 million of the $3 million to be funded under the royalty agreement, which entitles FinCanna to a perpetual royalty equal to 10 percent of consolidated gross revenues of ezGreen, subject to certain buy-back options. “The ezGreen team is committed to creating state of…

Continue Reading

WednesdayAug 08, 2018 9:34 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Enters Binding LOI with HOPE Cannabis Products

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned subsidiary, Pivot Naturals LLC, has entered into a binding Letter of Intent (“LOI”) with Healthcare Options for Patients Enterprises LLC, dba HOPE Cannabis Products ("HOPE"). HOPE is fully licensed to manufacture, distribute and sell cannabis products in Nevada, offering products such as effect-based vape cartridges, syringes, micro-dosed oral sprays, pre-rolls, infused pre-rolls, infused cold brew coffee and infused lemonade. Per the LOI, HOPE will manufacture and distribute Pivot Naturals' product line in Nevada and Pivot will manufacture and distribute HOPE's product line in California. Definitive agreements,…

Continue Reading

TuesdayAug 07, 2018 3:27 pm

CannabisNewsBreaks – The Flowr Corp.’s Chairman and Chief Strategist Discusses Company Activities and Outlook in Kahner Global Interview

Steve Klein, the chairman and chief strategist of The Flowr Corp., provided an overview of the company's activities and outlook during an interview that was posted on Kahner Global's website. Flowr is a Canadian licensed producer that focuses primarily on premium flower production. "On the financial side, we're working to complete a process that will lead to us being listed on the TSX Ventures exchange. That should be done by September. On the operating side, we're completing the build out of Kelowna this year, including the Hawthorne research center.  It's about 20% operational now but we need to finish it…

Continue Reading

TuesdayAug 07, 2018 10:21 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Successful Delivery of Nicotine Within Minutes in Edible Nicotine Study

Drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning announced that within minutes after dosing in an animal in vivo study, it has successfully delivered nicotine in an edible form into blood plasma. Per the update, Lexaria's DehydraTECH™ technology delivered nicotine with 90.2% greater delivery than the concentration-matched control formulation by the 10-minute mark and substantially greater absorption levels than the control formulation at all time intervals in the study. The company contracted a third-party laboratory to conduct the study which concentrated on detailed analysis of absorption over a 60-minute period. Lexaria's in vitro laboratory, in vivo…

Continue Reading

TuesdayAug 07, 2018 9:26 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Acquires Worldwide Rights to Solumer™ Oral Drug Delivery Technology

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced its entrance into a definitive agreement with SoluBest Ltd. to acquire the worldwide rights for the use, development and commercialization of its patented Solumer™ Oral Drug Delivery Technology. The innovative technology will be employed to improve the bioavailability, delivery and commercialization of biocannabis-based products. The delivery technology also encompasses SoluCBD and SoluTHC, ingredients for a new category of cannabis-infused non-alcoholic beverages. "The addition of Solumer™ further positions us to collaborate with multinational companies to introduce non-alcoholic cannabis-infused beverages to consumers. Pivot has the largest portfolio of platform technologies for…

Continue Reading

FridayAug 03, 2018 12:27 pm

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Releases Corporate Video Detailing Exclusive National Agreement with Natural Specialty Sales

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) earlier this week signed an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. Per the agreement, Phivida’s OKI brand of premium CBD products will be the exclusive CBD-infused beverage brand and health supplements products represented by NSS, giving the company access to over 2,400 retail locations in a $4.1 billion market. The OKI line is anticipated to launch during the third quarter of 2018. "Obviously, there's been a lot of hard work behind the scenes. We've been working on this agreement for months, and to see it come to fruition today…

Continue Reading

ThursdayAug 02, 2018 10:00 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Posts Record Date for Spinout Transaction

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTC: TGODF) this morning issued an update regarding its previously announced spinout transaction. The company will distribute a warrant in the new corporation, TGOD Acquisitions, to TGOD shareholders. Each warrant permits the holder to purchase a unit of TGOD Acquisitions at a price of $0.50 for a period of 30 days from completion of the spinout. Each unit is comprised of one common share and one additional warrant of TGOD Acquisitions. The record date for distribution of the warrants is anticipated to be on or about September 28,…

Continue Reading

ThursdayAug 02, 2018 9:48 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Adds Third Entry to Lineup of Cannabis Brands

Leading Canadian cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the launch of Lumina, an adult-use cannabis brand and product line designed with health and wellness in mind. Per the update, Lumina supports a holistic approach to mental and physical well-being, which ABcann highlights as a key consideration in the flourishing wellness sector. “Lumina is the third entry in ABcann’s growing lineup of cannabis brands, joining Beacon Medical and FIRESIDE in our premium portfolio,” Barry Fishman, CEO of ABcann, stated in the news release. “Our extensive experience growing premium cannabis, emphasis on quality, and dedication to…

Continue Reading

ThursdayAug 02, 2018 9:23 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Enters Exclusive Co-marketing and Distribution Agreement

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has entered into a definitive co-marketing and distribution agreement with S.T.U. GmbH. The Switzerland-based company manufactures and markets "Hemplix™" brand CBD oils. Per the terms of the agreement, Pivot's proprietary cannabinoid-derived products will be marketed and sold by S.T.U. online and in retail stores, where regulations permit, in the U.K., Switzerland, Germany, Austria and Italy. Pivot will distribute the Hemplix™ product line where regulations permit, and upon receiving required licenses from regulatory authorities, in Canada, Latin America and the United States. "As we continue to execute on…

Continue Reading